On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now Blog

All posts by Christopher

Geyser Brands Inc. (TSX.V: GYSR) Delivers Established Cannabis Labels to Consumer Health Care Markets

  • Geyser Brands recently received a processing license and implemented manufacturing at a licensed production (LP) facility
  • The company developed NanoFusion, an advanced nanotechnology drug-delivery system
  • GYSR recently acquired Solace Management Group Inc.

Now that cannabis is losing its illegitimacy, derivatives of the plant are permeating consumer markets at a rapidly growing pace, thanks to companies such as Geyser Brands Inc. (TSX.V: GYSR). The global cannabis-powered and science-led consumer health care company offers products in a diverse range of markets, from fast-moving consumer goods and over-the-counter pharmaceuticals to medical cannabis.

In October 2018, Geyser received its Health Canada cultivation license and, in June 2019, less than a year later, a standard processing license. Licenses for R&D and sales are pending. In addition, the company recently closed an acquisition that considerably increased its brand portfolio. Driven by a management team experienced in manufacturing and marketing, Geyser looks set to realize its vision of being a global player in the billion-dollar cannabis and plant-powered health care markets.

Given the company’s extensive brand portfolio, the world is Geyser’s oyster. GYSR has products in a number of global markets, including the trillion-dollar personal and skin-care market; the $575 billion personalized and complementary medicine market; the ballooning (CAGR 34.6 percent) legal-marijuana market, which has been forecasted to reach $146 billion by 2025; the $4.2 trillion wellness market; and the pet care market, which is worth around $132 billion.

Geyser recently closed on its acquisition of established hemp-brands manufacturer Solace Management Group Inc., which added two dozen wellness products and 57 SKUs to GYSR’s product lineup. The acquisition also comes with a 7,500-square-foot, GMP-compliant facility belonging to an existing innovation-hub and manufacturing subsidiary in Coquitlam, British Columbia (http://ibn.fm/StIcV).

Solace also owns a number of brands with leading market positions in Canada, including Apawthecary Pets, WildTails pet products, Apothecary Naturals and Apothecary Ink, all of which currently use hemp oil in their formulations. The brands are distributed by leading retailers across Canada including Bosley’s and Shoppers Drug Mart. In addition, Solace recently received approval for sales of a new pain-relief, roll-on product thanks to a natural product number issued by Health Canada (http://ibn.fm/yXFxK).

And that’s not the only good news for Geyser. In June 2019, Apothecary Botanicals, Geyser’s wholly owned licensed producer (LP), received a standard processing license from Health Canada, a key development that allows the production of a variety of products including tinctures and supplements (http://ibn.fm/Iym76).

In addition, Geyser has developed NanoFusion, an advanced nanotechnology drug-delivery system that transports therapeutic agents rapidly and efficiently directly to the bloodstream for maximum absorbency. In the past, a major challenge in producing cannabinoids for ingestion or absorption through the skin is their insolubility.

Cannabinoids are naturally hydrophobic (afraid of water), which makes it harder for the body to absorb them. The result is inconsistent, unreliable dosing and onset times of up to three hours. Geyser’s NanoFusion breaks down cannabinoid particles and combines them with naturally occurring surfactants that lower the surface tension between cannabinoids and water, resulting in a compound that is water compatible.

For more information, visit the company’s website at www.GeyserBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://ibn.fm/GYSR

Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) Targeting Trillion-Dollar Media Market with Proven Leadership Team

  • Streaming video-on-demand (SVOD) giants are ramping up spending on content
  • Forecasts for the global SVOD sector increased by 25 percent to $36 billion this year
  • Wonderfilm recently appointed PCG Advisory Inc. as its advisor for investor relations and strategic communications

Investors looking for opportunities in the booming mass media sector will likely find Wonderfilm Media Corporation (TSX.V: WNDR) (OTC: WDRFF) on their radars. Movies produced by Wonderfilm’s production team before they joined together to form Wonderfilm include ‘Get Out’ (2017), which cost $4.5 million to make and grossed $255 million at the box office; ‘BlacKkKlansman’ (2018), which grossed $93 million on a budget of $15 million; and ‘National Lampoon’s Christmas Vacation’, which has grossed $71 million on a budget of $25 million. With the global media-and-entertainment market forecast to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022 (http://ibn.fm/ZxClY), content creators like Wonderfilm are positioned to capitalize.

Based on current trends, cable and video are out, and streaming video on demand is in. Not so long ago, video rental shops were as ubiquitous as delis. However, in just a decade or so, technological developments have transformed America’s viewing habits. Mass adoption of subscription video-streaming services such as Amazon Prime Video, Hulu and Netflix continues to grow. As a result, global SVOD revenues are expected to increase 25 percent to $36 billion in 2019 (http://ibn.fm/U0TI0).

The SVOD behemoths are sucking up huge amounts of content. In 2018, Netflix spent $12.04 billion on content, up 35 percent from $8.9 billion in 2017, according to its fourth-quarter 2018 earnings report. In 2019, Apple plans to spend $6 billion on content, while Amazon will spend $7 billion.

In this competition for eyeballs, content is a critical factor. Wonderfilm is looking to provide what these giants need. The company retains a continuing annual production slate worth millions to meet the constant and growing need for content worldwide. Currently, Wonderfilm has 17 films ready to shoot with a combined budget of $58 million, featuring proven box office draws John Travolta, Nicholas Cage, Guy Pearce, Ryan Phillippe, Ron Pearlman, Steven Seagal, Anne Heche, Thomas Jane and Tyrese Gibson, as well as MMA legends Tito Ortiz and Chuck Liddell.

Travolta stars in Wonderfilm’s newly produced movie ‘The Fanatic’, which premiered in theaters across America in August 2019. Cage will appear in ‘Primal’, premiering in November, while ‘Disturbing the Peace’ will feature Guy Pearce in a lead role.

Earlier in October, Wonderfilm appointed PCG Advisory Inc., a leading investor relations and digital strategies firm, to serve as an advisor for its investor relations and strategic communications. The change in IR advisors reflects new market-driven opportunities for Wonderfilm resulting from the unprecedented worldwide appetite for streamed media content (http://ibn.fm/ISmPz).

Earlier this year, Wonderfilm formed a film-and-television sales/distribution joint venture with 101 Films. Launched at the 2019 Cannes Film Festival, Wonderfilm Global will generate revenue through presales of Wonderfilm projects and third-party films. The average Wonderfilm movie is presold for $5 million, garnering from $500,000 to $750,000 per sale as a sales commission. These commissions now stay in-house, with Wonderfilm Global expecting to sell 10 to 12 third-party films over the next year, generating roughly $6 million in commission income.

Wonderfilm is an entertainment company with offices in Beverly Hills, California, and Vancouver, British Columbia. The company’s main business is the production of high-quality feature films and episodic television that offer international appeal.

For more information, visit the company’s website at www.Wonderfilm.com

Fintech Holding Company Xalles Holdings Inc. (XALL) Sees Potential in Micro Trading Amid Crypto Volatility

  • Xalles Holdings has built a fintech services operation that focuses on an acquisition and accelerator mentoring strategy for establishing revenue partners and subsidiaries
  • Xalles’ revenue sharing agreement partner, ATN Trading, recently issued an article showing how its trading engine helped an investor through scalp trading (or “micro trading”) on a cost averaging basis as he rides out crypto market volatility and looks to potentially profit, even in a down cycle
  • Xalles recently reported its fifth consecutive quarter of revenue generation as the company’s subsidiaries push toward profitability and positioning the company as a dominant provider of fintech payment systems

Fintech holding company Xalles Holdings Inc. (OTC: XALL) is citing a recent article on bitcoin trading strategy issued by its revenue sharing agreement partner as a means by which savvy investors can maximize their profits amid the ever-volatile mood swings of the crypto market.

The article, by All The Numbers Trading Company LLC (d/b/a ATN Trading) President Brian Groot, proposes micro trading in the crypto market instead of adhering to the common adage that “it’s better to HODL than to trade.” His argument is that HODLing may allow an investor to eventually benefit as crypto bought at the peak of a cycle’s swing regains value after a market dip, but micro trading on a cost averaging basis can allow an investor to minimize the risks of price dips and actually come out ahead of a HODLing investor (http://ibn.fm/uFgkW).

Groot provides an example in which a new investor trading on ATN’s cryptocurrency trading engine recently put $10,000 into bitcoin (BTC) using a Coinbase Pro exchange account and a micro cost averaging strategy of buying .002 BTC at $5 intervals over time. The strategy included a sell order triggered whenever bitcoin’s price was 1.3 percent higher than the price at which the investor bought.

The example shows how, after 3,730 such micro trades during the course of two months, the investor’s portfolio value stood at $8,967.62, whereas simply buying and HODLing the cryptocurrency would have resulted in a portfolio of $7,368.41 – 22 percent less – at a time when the investor’s portfolio is already valued below the initial investment because of the market dip.

If the investor had settled for a HODLing strategy, his portfolio would be down 26 percent from its initial purchase price, but micro trading on a cost averaging basis through ATN’s engine mitigated that loss favorably by 10.3 percent. Since the investor didn’t cash out after those two months, there is still a good likelihood of seeing the investment’s return enter positive territory if the BTC price rises back above the peak where the cryptocurrency was purchased, Groot added.

“As the price of Bitcoin continues to show reliable volatility, there is a very real likelihood that… (the investor’s) portfolio value will exceed his original $10,000 investment EVEN before the price of BTC reaches his original entry point,” he continued.

Bitcoin has experienced a series of significant drops since rallying to August highs, putting its status as a cryptocurrency market driver in question (http://ibn.fm/rqgju), but companies such as ATN and Xalles are dedicated believers in the market who have “already accepted the risk and bitcoin’s volatility,” as Groot noted.

Xalles is focused on payment systems and solutions, actively searching for fintech acquisitions of merit and helping those acquisitions grow with financial, management and business development support as they are placed into a relevant program or subsidiary. The company’s subsidiaries provide investment management, post-payment auditing using a proprietary software platform, payment card financial services and rewards programs that include non-profit fundraising platforms.

Xalles CEO Thomas Nash noted in a September NetworkNewsAudio interview that the company’s revenue stream depends on a diversity of operations that have a common element – a business model that will set up a payment or financial transaction toll gate of some type (http://ibn.fm/86485).

The company’s client projects have included working with the U.S. Department of Defense, Mastercard, Citibank and U.S. Bank. Xalles recently reported its fifth consecutive revenue-producing quarter and plans for building revenues as it rolls out services and its proprietary technology during the coming year (http://ibn.fm/fGwZc).

For more information, visit the company’s website at www.Xalles.com

NOTE TO INVESTORS: The latest news and updates relating to XALL are available in the company’s newsroom at http://ibn.fm/XALL

OriginClear (OCLN) is “One to Watch”

  • Fully reporting, 10-year-old public company with 10,000+ shareholders
  • Direct and channel commercialization of its product lines in North America, leading the decentralized water treatment revolution with the Modular Water Systems™ product line, and well positioned for growth in the commercial and industrial ESG space
  • Commercializing its patented, chemical-free Electro Water Separation™ and Advanced Oxidation™ technologies through licensing and partnerships worldwide demonstrating a strong history of environmental stewardship
  • Made in USA – Texas-strong: fabrication, manufacturing and distribution of factory assembled, highest quality, containerized and packaged water systems and larger commercial and industrial custom-build, advanced water treatment systems
  • Advanced technology projects, supporting the boom in localized water treatment systems
  • Active licensee network in China, South Asia, Europe and the Middle East
  • A global network of partnerships and joint ventures
  • Acquisition strategy empowers companies to help water users treat and recycle their own water

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

  1. Water Treatment: achieving high grade purification.
  2. Water Conveyance: water transportation and pumping.
  3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

OriginClear is a growth story and positioned to take full advantage of a major shift from the city to the corporate user; while the company is already operating successfully with strong profit margins, an increasing customer base, and working on accretive acquisitions that could dramatically increase growth.

In just 10 years, the global water services market has doubled into a trillion-dollar industry. Yet, only 20 percent of all sewage, and 30 percent of all industrial waste, are ever treated. Water leakage results in the loss of 35 percent of all clean water across the planet; cutting that number in half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

We can no longer rely on giant, centralized water utilities to meet the challenge. That’s why more and more business users are doing their own water treatment and recycling. Whether by choice or because they have to, those businesses that invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of sight of the general public, self-reliant businesses are quietly building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which drive about a quarter of all professionally managed assets around the world, specifically include the key factor of how well corporations manage water.

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

For more information, visit the company’s website at www.OriginClear.com

NOTE TO INVESTORS: The latest news and updates relating to OCLN are available in the company’s newsroom at http://ibn.fm/OCLN

InsuraGuest Inc. Expands InsurTech Platform to Offer Specialized Guest Protection Insurance to EU and UK, Sets Sights on Asia for 2020

  • InsuraGuest’s Guest Protection Policy covers hotel and vacation rental guests against accidents and damage loss
  • The European hotel market is twice the size of that of the U.S., with a valuation of $218 billion; the U.S. vacation rental sector is estimated at $100 billion
  • InsuraGuest’s platform can integrate with 70 hotel and vacation rental property management systems and has the potential to access 40,000 properties worldwide

Service-as-a-software (SaaS) company InsuraGuest Inc. is working to expand the scope of its InsurTech platform and insurance products to cover European Union member states and the United Kingdom, according to a recent company press release. InsuraGuest has already signed a letter of intent with a licensed Master General Agent operating in these markets, which will allow the company to distribute its products and proprietary platform to the hotel and vacation rental markets in these regions.

The move is likely to bring multiple benefits and opportunity for increased revenue and future growth, as this is a very lucrative market almost twice larger than the U.S. market. According to InsuraGuest CEO Douglas Anderson, there were 2.8 billion hotel nights stayed in Europe, compared to approximately 1.1 billion in the U.S. in 2018.

In the same period, there were 2.6 billion hotel nights stayed in Asia – a market InsuraGuest is also planning to enter in the near future. Currently, the U.S. hotel industry has reached $218 billion in annual revenue, with roughly $100 billion spent on vacation rentals last year (http://ibn.fm/Mu7CF). With distribution in the U.S. and Europe, InsuraGuest will reach a combined demographic of approximately 3.9 billion hotel stays and will double its vacation rental opportunities.

The company’s completed property management system integration currently covers 85 percent of the hotel market. Its InsurTech proprietary platform can integrate with 70 different hotel property management systems, obtaining access to approximately 40,000 properties. In addition, InsuraGuest™ is being integrated with vacation rental property management systems like Hostfully Inc. out of San Francisco and their system Orbirental, which currently has approximately 2,500 properties onboarded.

The platform delivers a specialized guest protection policy to vacation or hotel rental. Created specifically for InsuraGuest, this policy is the first line of defense against accidents and losses both for the guest and the hotel or vacation rental property. Properties can buy the InsuraGuest Guest Protection Policy, which is extended to each individual guest at the time of check-in until check-out. The policy covers loss and accident damages.

InsuraGuest created this insurance product and markets it to hotels and other vacation properties in an attempt to fill an existing gap in travelers’ insurance. Conventional insurance fails to adequately cover the full scope of risks that travelers and hotel or property owners face. There is a lot that can happen inside hotels or other travel properties. Many travelers labor under the misconception that losses or accidents happening at vacation properties are automatically covered by the property owner’s insurance. In cases where an incidence of damage or an accident cannot be attributed to the property directly, the guest may have no claim to coverage at all. InsuraGuest’s InsurTech platform aims to change this.

The company covers up to $5,000 for death or dismemberment, up to $25,000 for medical care following an accident, up to $2,500 for lost or stolen goods, and $1,000 for damage to a occupied room accidentally incurred by the guest.

InsuraGuest is currently focused mostly on the U.S. market, where it operates coast-to-coast. The company expects to be licensed to sell insurance under its own agency nationwide in the very near future. After the move to Europe and the U.K., InsuraGuest is planning to launch its proprietary platform and insurance products in Asia by mid-2020.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

As CBD Shines, Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Fuels Growth of National and Global Distribution Networks

  • The lucrative U.S. CBD market is estimated to reach $5 billion this year, marking an impressive 706 percent increase from 2018
  • The growing trend is expected to continue, with industry forecasts putting CBD’s CAGR at 107 percent to reach $23.7 billion by 2023
  • Wildflower Brands is well positioned to take advantage of this trend and expand its market presence domestically and internationally
  • The company’s branded premium products are currently available at 600 locations

The cannabis industry is historically a newcomer to global markets, yet legal sales worldwide reached $11 billion in 2018 from only $3.4 billion 2014 (http://ibn.fm/a8o2Y). The industry’s outlook continues to improve and exponential growth is anticipated, with a projected increase every year, to potentially reach $75 billion by 2030 (http://ibn.fm/PLwRo).

One segment of the industry, however, is set to outperform all others – CBD (cannabidiol). Investors are becoming increasingly aware of CBD’s potential and expected growth. This cannabinoid can be extracted from both the cannabis and the hemp plant, but since hemp plants are considerably cheaper to grow, hemp is typically the preferred crop choice for extraction, which can explain CBD’s star performance.

Industry watchdogs are in full agreement on the CBD market growth trend. Market research company Brightfield Group projected a 706 percent year-on-year increase in U.S. CBD product sales in 2019, to reach $5 billion (http://ibn.fm/Ln9qH). Additionally, the report indicates that CBD sales will reach $23.7 billion by 2023, growing at a compound annual growth rate of 107 percent. For comparison, about $620 million worth of CBD products were sold in the U.S. in 2018.

Companies such as Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) are uniquely positioned to take advantage of the CBD popularity boom but focusing on developing and designing premium branded products for the increasingly discerning consumer. Operating out of Washington State, the company is already selling its products throughout the U.S., has recently entered the Canadian market and aims to further expand its network to other international markets in the future.

As a result of various retail collaborations and strategic partnerships, Wildflower Brands’ CBD products are now available at 600 locations across America, including in over 260 Dillard’s department stores (http://ibn.fm/KyxQW). The initial purchase ordered enabled company products to reach several new states, according to Wildflower Brands CEO William McLean.

Wildflower products are also available at 100 Earthbound Trading locations nationwide, 20 premium health and wellness stores throughout Manhattan, as well as wellness guru Joel Warren’s Saks Fifth Avenue salon (http://ibn.fm/KtIUU).

The company recently completed the strategic acquisition of Canadian-based City Cannabis Corp, which gives it access to four retail stores in Vancouver, British Columbia. Two of these stores were opened in August 2019 (http://ibn.fm/DiFNl).

Wildflower continues to expand into large retail chains, launch new products, and execute its lucrative marketing strategy for e-commerce. A 10,000-square-foot manufacturing facility will be completed in November to boost production, as part of the company’s domestic expansion plans. In terms of online sales, the company receives an average of 900 orders per month and achieved a 3.44 percent conversion rate in October 2019. It boasts a 39 percent returning customer rate and a 300 percent revenue growth rate. The online store, wildflowerUS.com, is in the top two percent of all Shopify stores that launched in 2017.

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://ibn.fm/WLDFF

SinglePoint Inc. (SING) Sees Record Hemp Cigarette Sales, CEO Forecasts Multimillion Dollars in Sales for 2020

  • SinglePoint returns from NACS show with 75 leads and potential for 3,000 accounts
  • The company closed a record $50,000 in hemp-cigarette sales onsite
  • SING’s Direct Solar subsidiary continues to post record sales figures

SinglePoint Inc. (OTCQB: SING), a diversified holding company with operations in multiple industries and verticals including legal cannabis, just returned from a stellar showing at the October National Association of Convenience Stores (NACS) Show, held in Las Vegas. Singlepoint founder and CEO Greg Lambrecht shared the positive news this week during an interview on MoneyTV with Donald Baillargeon (http://ibn.fm/aYbxy).

“We just really did well there at the NACS show,” Lambrecht stated in the interview, noting that SING was one of the only booths to feature hemp cigarettes. “We did a pretty massive direct-marketing campaign to get people to the booth. We were busy the whole three days, and we had six people manning the booth. We probably had about four to five hundred people come through our booth. We just put together 75 leads in SalesForce, which equals about 3,000 accounts.”

Lambrecht noted that many of the visitors to the booth were buyers for chain stores, some numbering in the hundreds. The company is now following up on each lead.

In addition to following up with interested buyers, SING is also busy filling orders that were actually placed during the show – the company closed on $50,000 worth of sales onsite. “It’s incredible,” said Lambrecht, who noted that taking onsite orders wasn’t even an option in his “previous life” doing trade shows. “And now we’re able to swipe credit cards right on our phones and take orders at the show.”

Singlepoint isn’t worried about meeting demand for its popular Pure American Hemp Cigarettes. The company ordered two pallets of product delivered to its California facility: the first will be used to fill the onsite orders, and the second will provide ready inventory for anticipated orders from NACS leads.

“We’re expecting additional sales,” Lambrecht continued. “We’re well on our way. We could be one of the leaders in the hemp cigarette business.” The Singlepoint exec noted that the company plans to attend future shows as well, including the MJBizCon conference slated for December. “We picked the right product, and we really have the right team,” he says. “We expect huge things from the hemp business.”

In addition to SING’s booming hemp cigarette business, Lambrecht noted that there was “nothing but great news on Direct Solar as well.” Singlepoint’s Direct Solar subsidiary (http://ibn.fm/42Udy) is a solar energy brokerage focused on finding and installing “the best available solar-energy system for any building residential or commercial for no money down, no cost for an estimate.” The company, which SING acquired earlier this year, has surpassed expectations by signing contracts to deploy more than $1.7 million in solar installs in a one-month period, then adding up to a two-month total of nearly $3.5 million in contracts.

“[Direct Solar is] doing as well as they ever have and even better,” Lambrecht added. “Their sales are getting better every month as they grow…We’re pretty excited to show the audience and all of our shareholders our revenues for third quarter. Singlepoint is continuing to increase their revenues and their profits and their balance statement. This is really going to be a great year for us in 2020. I expect again to do somewhere between $15 and $20 million in revenue, and I expect the stock to follow.”

Singlepoint Inc. is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Receives Oil Sales License for Blissco Wellness Brand

  • SPRWF subsidiary Blissco recently received Health Canada licensing approval to sell cannabis oils
  • Blissco expected to produce more than seven million tincture bottles annually
  • Supreme Cannabis says that the subsidiary will make a significant impact on its FY2020 revenues

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of cannabis companies including subsidiary Blissco Cannabis Corp., announced that Blissco has received licensing approval from Health Canada for the sale of cannabis oils from its Langley, British Columbia, facility (http://ibn.fm/KvUBF). The highly anticipated licensing means that Blissco now has government approval to sell full spectrum cannabidiol (CBD) oil products.

Supreme Cannabis closed its acquisition of Blissco—a wellness cannabis brand and multiprocessor and distributor based in British Columbia—in the first quarter of FY2020 (http://ibn.fm/OYwtS). It has been making strategic moves toward this licensing milestone. By improving the efficiency and focus of Blissco’s business operations, including initiating construction on a large-scale ethanol-based extraction lab, Supreme Cannabis has been working to expand Blissco’s extraction capabilities. The company predicts that its facility will be able to produce over seven million tincture bottles annually, making the Blissco brand a significant driver to SPRWF’s projected revenue in FY2020.

The subsidiary’s ability to produce and sell high-quality CBD oil products means Blissco sales will be a significant factor in SPRWF’s projected FY2020 revenue. The company expects to launch its first CBD oil product in the Canadian market by the second quarter of FY2020 with plans to follow up that initial product offering with a suite of complementary cannabis extract products in subsequent quarters.

“With the receipt of the license and expanded extraction capacity, Blissco will be positioned to address the growing unmet demand for high-quality, CBD oil products across Canada,” said Supreme Cannabis CEO Navdeep Dhaliwal. “Blissco’s legacy of premium, whole-flower products established a brand that represents quality and authenticity to wellness consumers. For over a year, Blissco’s team developed advanced oil-processing and formulation capabilities based on the same ethos. Consumers will soon be able to experience high-quality CBD oil products from a premium wellness brand they have come to trust.”

In addition, SPRWF has appointed Todd McAdam as general manager of the Blissco facility; his responsibilities will include managing and supporting the production, sale, and distribution of Blissco’s high-quality products. A highly experienced operations professional, McAdam has spent more than 30 years working in the food and beverage industries. Most recently, he served as general manager at Labatt Breweries of Canada’s Turning Point Brewery in British Columbia.

In addition to Blissco, the Supreme Cannabis portfolio includes 7ACRES, an award-winning brand; Cambium Plant Sciences, a cultivation IP and plant-genetics company; Medigrow Lesotho, a Southern Africa cannabis-oil producer; Supreme Heights, the investment platform focused on CBD; and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

Endonovo Therapeutics Inc. (ENDV) Appoints Strategic Advisor to the CEO to Explore Growth Opportunities

  • The new strategic advisor, Dr. William Li, is a globally recognized medical professional
  • One of Li’s primary specialties is the identification of unmet medical market needs that can be addressed through technological advances
  • Endonovo is working to develop solutions for major therapeutic needs, especially in regard to pain management
  • Its Electroceutical® SofPulse® is clinically proven to provide post-operative pain relief and speed up recovery

On September 30, 2019, Endonovo Therapeutics Inc. (OTCQB: ENDV), a commercial-stage developer of innovative medical devices, announced the appointment of Dr. William Li as a strategic advisor to the CEO. The role of Li would be to strategically explore growth opportunities within the Endonovo target markets, the company said in a press release (http://ibn.fm/mCqAT).

“Dr. Li is a globally recognized medical professional and a business visionary with a strong track record of success,” Endonovo Therapeutics CEO Alan Collier said in a news release. Just like the Endonovo team, Li sees the long-term potential of medical innovations and their ability to change the industry, Collier added.

According to Li, “Endonovo has a strong technology platform with game changing potential. The company’s clinical-stage wearable Electroceutical® therapeutic device, SofPulse®, can address pain, wound healing, post-surgical pain, edema, central nervous system disorders and various other conditions.”

“Endonovo is poised to go to the next level across a range of industry verticals. I look forward to working with Alan and the Endonovo team to evaluate the Company’s operational and strategic opportunities,” Li added.

One of Li’s focal areas of experience is the identification of unmet needs in the healthcare space, especially if cost-effective innovative technology can offer a solution.

Li is the CEO and co-founder of the Angiogenesis Foundation. He gained experience under the guidance of Dr. Judah Folkman – one of the angiogenesis pioneers. Li has been actively involved in angiogenesis and clinical research for more than 30 years. Li graduated from Harvard and completed his medical residency training at Massachusetts General Hospital in Boston. He serves as a consultant to various leading global public and private companies.

Endonovo Therapeutics is currently developing solutions to meet major therapeutic needs. The company’s innovative SofPulse® device delivers clinically proven post-operative pain relief for patients, reducing the need for opioid use.

SofPulse® delivers targeted pulsed electromagnetic field therapy to significantly speed up the recovery process after surgery. It improves the patient’s natural recovery experience and can be a better alternative to opioid-based pain medications, thus helping tackle the current opioid crisis.

According to U.S. federal statistics, opioids kill more people per year than automobile accidents. In 2018 alone, 68,000 Americans died of a drug overdose stemming from opioid abuse (http://ibn.fm/BsSiX). This is a significant increase from 18,515 opioid-related deaths in 2007.

The general population and the medical community are both pushing for a change in which chronic and post-operative pain are handled. Unfortunately, few alternatives to opioids exist. SofPulse® is one of the innovative solutions that could diminish the use of medications and give patients satisfactory pain management.

Endonovo’s therapy is cleared by the U.S. Food and Drug Administration for the palliative treatment of post-surgical pain and edema. It is also CE-marked in the European Economic Area for the promotion of wound healing and the palliative treatment of post-surgical pain and edema.

For more information, visit the company’s website at www.Endonovo.com

NOTE TO INVESTORS: The latest news and updates relating to ENDV are available in the company’s newsroom at http://ibn.fm/ENDV

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Projects Up to $180M in Net Revenues for FY2020

  • In a YouTube interview, Supreme Cannabis CEO Navdeep Dhaliwal stated that investors should focus on the company’s strong balance sheet
  • Supreme Cannabis reported $41.8 million in sales for FY2019, as compared to $8.9 million in FY2018, marking a 370 percent year-over-year jump; the company also reported its first positive adjusted EBITDA
  • Dhaliwal further noted that the performance of subsidiary 7ACRES is key to the company’s growth

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of cannabis companies, projects that its fiscal 2020 net revenues will increase to an estimated $150 million to $180 million, with a positive adjusted EBITDA. In FY2019, Supreme Cannabis reported net revenues of $41.8 million, including its first positive adjusted EBITDA quarter of $3.2 million (http://ibn.fm/PkcSB). FY2019 net revenue total itself was a 370 percent improvement compared to the company’s $8.9 million in cannabis sales posted for FY2018.

Supreme Cannabis CEO and director Navdeep Dhaliwal said during a YouTube interview with Evan Veryard, president of Capital 10X, that he believes the cannabis industry is entering a period where companies with strong business fundamentals will dominate.

“It’s an inflection point,” Dhaliwal noted in the interview in reference to Supreme Cannabis’ projections for FY2020 net revenues (http://ibn.fm/QiIVS). “You’re starting to see a real separation between strong businesses and strong core operations that are going to be strong, dominant long-term with competitive advantage. We’re excited about this period in the market because business fundamentals are going to take over and a lot of the noise is going to go away.”

In the interview, Dhaliwal noted that investors should look at the strong balance sheet of Supreme Cannabis. “We have a very healthy cash balance, and we’re fully funded for all our planned business objectives,” he observed, adding that Supreme Cannabis is in a good position to receive non-diluted debt financing from tier-one lenders and to “fulfill all of our obligations, specifically to debentures which are due in 2020 and 2021… It is really about balance: building strong businesses, investing prudently in growth and taking a data-driven approach. Test and validate and then a scale approach. That’s our strategy.”

As a diversified consumer-driven business, Supreme Cannabis is also focused on high-margin, premium quality products, Dhaliwal observed. The company wants to please its highly discerning consumers with the highest quality products. One example of that focus, he pointed out, is the company’s 7ACRES subsidiary, which recently launched Jack Haze, its first proprietary strain.

Jack Haze is 7ACRES’ first sativa-dominant strain with rare sensory characteristics (http://ibn.fm/ejmYM). Plans call for more unique strains to be introduced in the future as the company differentiates 7ACRES’ high-end flower offering and earns premium pricing across Canada.

The Supreme Cannabis portfolio includes 7ACRES, an award-winning brand; Cambium Plant Sciences, a cultivation IP and plant-genetics company; Medigrow Lesotho, a Southern Africa cannabis-oil producer; Supreme Heights, the investment platform focused on CBD; Blissco Cannabis Corp, a wellness cannabis brand and a multiprocessor and distributor based in British Columbia; and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

Last Tweets

Follow us: @Buy_Stocks_Now

From Our Blog

Geyser Brands Inc. (TSX.V: GYSR) Delivers Established Cannabis Labels to Consumer Health Care Markets

October 22, 2019

Geyser Brands recently received a processing license and implemented manufacturing at a licensed production (LP) facility The company developed NanoFusion, an advanced nanotechnology drug-delivery system GYSR recently acquired Solace Management Group Inc. Now that cannabis is losing its illegitimacy, derivatives of the plant are permeating consumer markets at a rapidly growing pace, thanks to companies […]

Rotate your device 90° to view site.